Cargando…

Antiretroviral drug resistance and viral tropism in HIV-1 CRF06_cpx infected patients failing antiretroviral (ARV) therapy

Detalles Bibliográficos
Autores principales:	Pauskar, Merit, Huik, Kristi, Avi, Radko, Kallas, Eveli, Jõgeda, Ene-Ly, Karki, Tõnis, Semjonova, Svetlana, Smidt, Jelena, Novikova, Lilia, Ainsalu, Külliki, Lutsar, Irja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072446/ http://dx.doi.org/10.1186/1471-2334-14-S4-O22

Ejemplares similares

Full-length genome sequences of Estonian HIV-1 CRF06 and Eastern-European subtype A1 recombinant forms
por: Avi, Radko, et al.
Publicado: (2014)

The concordance of the limiting antigen and the Bio-Rad avidity assays in persons from Estonia infected mainly with HIV-1 CRF06_cpx
por: Huik, Kristi, et al.
Publicado: (2019)

HTLV-1/2 is rare among Eastern-European intravenous drug users (IDUs)
por: Jõgeda, Ene-Ly, et al.
Publicado: (2015)

A CCL5 Haplotype Is Associated with Low Seropositivity Rate of HCV Infection in People Who Inject Drugs
por: Huik, Kristi, et al.
Publicado: (2016)

Dynamics of hepatitis C epidemic among people living with HIV in Estonia based on Estonian HIV cohort study
por: Kase, Kerstin, et al.
Publicado: (2021)

Co-infection with hepatitis C virus (HCV) in Estonian intravenous drug users HIV epidemic
por: Huik, Kristi, et al.
Publicado: (2014)

CCR5 Haplotypes Influence HCV Serostatus in Caucasian Intravenous Drug Users
por: Huik, Kristi, et al.
Publicado: (2013)

SARS-CoV-2 dual infection with Delta and Omicron variants in an immunocompetent host: a case report
por: Abroi, Aare, et al.
Publicado: (2022)

Environmental Risk Characterization of an Antiretroviral (ARV) Lamivudine in Ecosystems
por: Omotola, Elizabeth Oyinkansola, et al.
Publicado: (2021)

Identification of a new circulating recombinant form of human immunodeficiency virus type 1, CRF124_cpx involving subtypes A, G, H, and CRF27_cpx in Angola
por: Da Silva, Rayana Katylin Mendes, et al.
Publicado: (2022)

COVID-19 pandemic and antiretrovirals (ARV) availability in Nigeria: recommendations to prevent shortages
por: Dada, David Adelekan, et al.
Publicado: (2020)

Patent Pooling for Promoting Access to Antiretroviral Drugs (ARVs) – A Strategic Option for India
por: Satyanarayana, Kanikaram, et al.
Publicado: (2010)

Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria
por: Eluwa, George I, et al.
Publicado: (2012)

Correction: Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria
por: Eluwa, George I, et al.
Publicado: (2012)

Antiretroviral (ARV) Therapy in Resource Poor Countries: What do we Need in Real Life?
por: Castelli, Francesco, et al.
Publicado: (2010)

Trends in Decline of Antiretroviral Resistance among ARV-Experienced Patients in the HIV Outpatient Study: 1999–2008
por: Buchacz, Kate, et al.
Publicado: (2012)

LB5. Safety of In Utero Antiretroviral (ARV) Exposure: Neurologic Outcomes in HIV-Exposed, Uninfected Children
por: Crowell, Claudia S, et al.
Publicado: (2018)

Emergence as an outbreak of the HIV-1 CRF19_cpx variant in treatment-naïve patients in southern Spain
por: González-Domenech, Carmen M., et al.
Publicado: (2018)

Pharmaceutical Equivalence of Distributed Generic Antiretroviral (ARV) in Asian Settings: The Cross-Sectional Surveillance Study – PEDA Study
por: Sapsirisavat, Vorapot, et al.
Publicado: (2016)

Antiretroviral (ARV) Drug Resistance and HIV-1 Subtypes among Injecting Drug Users in the Coastal Region of Kenya
por: Ng'ong'a, Gabriel O., et al.
Publicado: (2022)

A putative HIV-1 subtype C/CRF11_cpx unique recombinant from South Africa
por: Bessong, Pascal Obong, et al.
Publicado: (2016)

CRF19_cpx is an Evolutionary fit HIV-1 Variant Strongly Associated With Rapid Progression to AIDS in Cuba
por: Kouri, Vivian, et al.
Publicado: (2015)

Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?
por: Padari, Helgi, et al.
Publicado: (2016)

The impact of transient combination antiretroviral treatment in early HIV infection on viral suppression and immunologic response in later treatment
por: Pantazis, Nikos, et al.
Publicado: (2016)

Identification of New HIV-1 Circulating Recombinant Forms CRF81_cpx and CRF99_BF1 in Central Western Brazil and of Unique BF1 Recombinant Forms
por: Reis, Mônica N. G., et al.
Publicado: (2019)

HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form
por: de Silva, Thushan I, et al.
Publicado: (2010)

Unassigned complex unique recombinant forms related to CRF36_cpx in children identified in an HIV-1 outbreak in Pakistan
por: Abidi, Syed Hani, et al.
Publicado: (2022)

Projected Uptake of New Antiretroviral (ARV) Medicines in Adults in Low- and Middle-Income Countries: A Forecast Analysis 2015-2025
por: Gupta, Aastha, et al.
Publicado: (2016)

550. Adherence and Persistency With Modern Single vs. Multi-Tablet Antiretroviral (ARV) Regimens in First Treatment of HIV in Clinical Practice
por: Mills, Anthony, et al.
Publicado: (2018)

Divergent HIV-1 strains (CRF92_C2U and CRF93_cpx) co-circulating in the Democratic Republic of the Congo: Phylogenetic insights on the early evolutionary history of subtype C
por: Villabona Arenas, C J, et al.
Publicado: (2017)

Genome Sequence of a Novel HIV-1 Circulating Recombinant Form (CRF77_cpx) Identified among Blood Donors in Malaysia
por: Tee, Kok Keng, et al.
Publicado: (2017)

Molecular Antiretroviral Resistance Markers of Human Immunodeficiency Virus-1 of CRF01_AE Subtype in Bali, Indonesia
por: Budayanti, Nyoman Sri, et al.
Publicado: (2018)

Characterization of a novel HIV-1 circulating recombinant form, CRF91_cpx, comprising CRF02_AG, G, J, and U, mostly among men who have sex with men
por: Topcu, Cicek, et al.
Publicado: (2022)

Impact of baseline HIV-1 tropism on viral response and CD4 gains in antiretroviral-naïve patients
por: Seclén, E, et al.
Publicado: (2010)

Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South Africa: a cross sectional study
por: Naidoo, Pamela, et al.
Publicado: (2013)

Reducing Delays to Antiretroviral (ARV) Receipt in Children Prescribed Post-Exposure Prophylaxis (PEP) for HIV: Meds-in-Hand and a Multidisciplinary Team Approach
por: Epstein, Rachel, et al.
Publicado: (2017)

No significant association between patient self-reported non-adherence to antiretrovirals and HIV-tropism: a preliminary analysis
por: Ammassari, A, et al.
Publicado: (2012)

Immune reconstruction effectiveness of combination antiretroviral therapy for HIV-1 CRF01_AE cluster 1 and 2 infected individuals
por: Li, Kang, et al.
Publicado: (2021)

New ARV drugs
por: Gulick, Roy
Publicado: (2014)

HIV-1 subtype and viral tropism determination for evaluating antiretroviral therapy options: an analysis of archived Kenyan blood samples
por: Lihana, Raphael W, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_v744ql5bfeterlkli4gsdv244d